COL:ASXColes Group Ltd. Analysis
Data as of 2026-03-10 - not real-time
A$20.49
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Coles Group is trading at a price that is substantially higher than its discounted cash‑flow estimate, suggesting an overvalued valuation. The 20‑day SMA sits just above the 50‑day SMA while both remain below the long‑term 200‑day SMA, indicating a neutral to slightly bearish bias. A sub‑40 RSI and a negative MACD histogram reinforce modest oversold pressure but also bearish momentum. Volume has been picking up, yet the stock slipped after the recent ex‑dividend date and a miss on half‑year earnings. Despite a solid dividend yield, the payout ratio is high, raising questions about sustainability. The company’s revenue is growing modestly and margins are thin, keeping earnings pressure high.
Coles operates in the consumer‑defensive grocery sector, which traditionally buffers earnings against economic cycles. However, regulatory scrutiny and intense competition from rivals add medium‑to‑high headwinds. Its beta is slightly negative, implying low correlation with broader market moves, but volatility remains elevated. The balance sheet shows a high debt‑to‑equity ratio, limiting financial flexibility. Given the overvalued price, bearish technical signals, and earnings uncertainty, short‑term downside risk appears pronounced. Over the longer horizon, the defensive positioning and attractive dividend could support a rebound if cost pressures ease.
Coles operates in the consumer‑defensive grocery sector, which traditionally buffers earnings against economic cycles. However, regulatory scrutiny and intense competition from rivals add medium‑to‑high headwinds. Its beta is slightly negative, implying low correlation with broader market moves, but volatility remains elevated. The balance sheet shows a high debt‑to‑equity ratio, limiting financial flexibility. Given the overvalued price, bearish technical signals, and earnings uncertainty, short‑term downside risk appears pronounced. Over the longer horizon, the defensive positioning and attractive dividend could support a rebound if cost pressures ease.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 8/10
Key Factors
- price significantly above intrinsic DCF estimate
- bearish technical indicators (negative MACD, SMA alignment)
- recent earnings miss and ex‑dividend price drop
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- defensive sector provides earnings stability
- attractive dividend yield despite sustainability concerns
- ongoing regulatory and competitive pressures
Long Term
> 3 yearsPositive
Model confidence: 6/10
Key Factors
- long‑term consumer staples demand
- potential for cost‑structure improvements
- high dividend yield as a total return component
Key Metrics & Analysis
Financial Health
Revenue Growth2.50%
Profit Margin2.25%
P/E Ratio27.0
ROE26.52%
ROA5.75%
Debt/Equity272.26
P/B Ratio7.1
Op. Cash FlowA$3.1B
Free Cash FlowA$1.3B
Technical Analysis
TrendNeutral
RSI36.2
SupportA$20.10
ResistanceA$22.38
MA 20A$21.58
MA 50A$21.38
MA 200A$21.90
MACDBearish
VolumeIncreasing
Fear & Greed Index76.91
Valuation
Fair ValueA$7.97
Target PriceA$22.75
Upside/Downside11.04%
GradeOvervalued
TypeGrowth
Dividend Yield3.56%
Risk Assessment
Beta-0.13
Volatility28.90%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.